Detalhe da pesquisa
1.
Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int
; 17(3): 227-232, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29709351
2.
Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int
; 14(4): 361-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26256079
3.
[Down-regulated clusterin expression enhances sensitivity of hepatoma cells to anti-cancer drugs].
Zhonghua Gan Zang Bing Za Zhi
; 23(11): 844-8, 2015 Nov.
Artigo
em Chinês
| MEDLINE | ID: mdl-26743245
4.
Glypican-3 as a specific biomarker for hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int
; 14(2): 122-3, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25865682
5.
Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.
World J Gastroenterol
; 22(14): 3829-36, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27076768